Your browser doesn't support javascript.
loading
Effect of OTX-101 in Patients with Dry Eye Disease at Day 14 of Treatment: Ocular Surface Endpoint Results from the Phase 2b/3 Clinical Trial.
Schechter, Barry A; Urbieta, Maitee; Bacharach, Jason; Toyos, Melissa; Smyth-Medina, Robert; Mitchell, Brittany; Luchs, Jodi I.
Afiliação
  • Schechter BA; Florida Eye Microsurgical Institute, Boynton Beach, FL, USA.
  • Urbieta M; Medical Affairs North America, Sun Pharmaceutical Industries, Inc., Princeton, NJ, USA.
  • Bacharach J; North Bay Eye Associates, Petaluma, CA, USA.
  • Toyos M; Toyos Clinic, Nashville, TN, USA.
  • Smyth-Medina R; North Valley Eye Medical Group, Inc., Mission Hills, CA, USA.
  • Mitchell B; Medical Affairs North America, Sun Pharmaceutical Industries, Inc., Princeton, NJ, USA.
  • Luchs JI; Florida Vision Institute, West Palm Beach, FL, USA.
Clin Ophthalmol ; 16: 4145-4151, 2022.
Article em En | MEDLINE | ID: mdl-36536927
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Ano de publicação: 2022 Tipo de documento: Article